Skip to main content
OpenTrials
Completed

NCT Number: NCT03691571

Esophageal Cooling for AF Ablation

The purpose of this study is to determine if esophageal cooling using the Attune Medical Esophageal Heat Transfer Device (EnsoETM) limits the number or seriousness of injury to the esophagus during atrial fibrillation ablation procedures. The EnsoETM is an FDA cleared device used for temperature management, but is not routinely used during atrial fibrillation ablation procedures.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pennsylvania - Perelman Center

Philadelphia, Pennsylvania, 19104, United States

About this study

The EnsoETM is a non-sterile multi-lumen silicone tube placed in the esophagus for the purpose of cooling or warming a patient while simultaneously allowing gastric decompression and drainage. Modulation and control of the patient's temperature is achieved by connecting the EnsoETM to an external heat exchanger. Two lumens connect to the external heat exchanger, while a third central lumen provides stomach access for connection to a fluid collection device with low intermittent suction for gastric decompression. The EnsoETM is made of standard medical-grade silicone. It is a single-use, disposable, non-implantable device with an intended duration of use of 72 hours or less. Distilled water circulates within the EnsoETM just like a water blanket.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients above the age of 18 years old.
  • Patients with the diagnosis of atrial fibrillation undergoing clinically indicated de-novo AF ablation procedure.
  • Patients must be able to understand and critically review the informed consent form.

Exclusion criteria

  • Patients whom are unable to provide informed consent.
  • Patients with contraindication to EGD.
  • History of prior AF ablation procedures.
  • Significant co-morbidities that preclude standard ablation procedure.
  • Patient is ineligible for EnsoETM placement due to:
  • Known esophageal deformity or evidence of esophageal trauma (for example history of esophagectomy, previous swallowing disorders, achalasia).
  • Known ingestion of acidic or caustic poisons within the prior 24 hours.
  • Patients with <40 kg of body mass.

Treatment and study plan

Esophageal Cooling

Device

The EnsoETM is a non-sterile multi-lumen silicone tube placed in the esophagus for the purpose of cooling or warming a patient while simultaneously allowing gastric decompression and drainage.

Other names: Attune Medical Esophageal Heat Transfer Device, EnsoETM

Control

Device

Standard of care involves standard temperature probe monitoring.

Other names: Standard of care

Primary outcomes

  1. Number and Percentage of Participants With Esophageal Thermal Injury

    Time frame: Day 1 to 2

    Any injury, occurrence rate measured by EGD

  2. Number and Percentage of Participants With Esophageal Injury Based on Severity

    Time frame: Day 1 to 2

    The severity of injury measured by EGD

Secondary outcomes

  1. Posterior Wall Ablation Parameters: Temperature

    Time frame: Day 0

    Catheter Temperature

  2. Posterior Wall Ablation Parameters

    Time frame: Day 0

    Impedance drop (absolute difference)

  3. Occurrence of Acute PV Reconnection

    Time frame: Day 0

    Number of Participants with Acute PV Reconnection

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • Attune Medical

Registry information

Official study title

Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation Ablation (eCoolAF)

Acronym: eCoolAF

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Oct 1, 2018
Registry last updated
Oct 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.